1. Home
  2. ARAY vs KYNB Comparison

ARAY vs KYNB Comparison

Compare ARAY & KYNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Accuray Incorporated

ARAY

Accuray Incorporated

HOLD

Current Price

$0.13

Market Cap

31.3M

Sector

Health Care

ML Signal

HOLD

Logo Kyntra Bio Inc. Common Stock

KYNB

Kyntra Bio Inc. Common Stock

HOLD

Current Price

$4.61

Market Cap

32.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARAY
KYNB
Founded
1990
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.3M
32.8M
IPO Year
2006
2014

Fundamental Metrics

Financial Performance
Metric
ARAY
KYNB
Price
$0.13
$4.61
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
★ $38.50
AVG Volume (30 Days)
★ 11.1M
21.1K
Earning Date
11-04-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
87.50
★ 9552.08
EPS
★ N/A
N/A
Revenue
N/A
★ $6,440,000.00
Revenue This Year
$2.75
N/A
Revenue Next Year
$2.35
$14.12
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.13
$4.85
52 Week High
$1.60
$9.66

Technical Indicators

Market Signals
Indicator
ARAY
KYNB
Relative Strength Index (RSI) 26.49 24.00
Support Level N/A N/A
Resistance Level $0.29 $7.41
Average True Range (ATR) 0.02 0.35
MACD -0.01 -0.07
Stochastic Oscillator 3.93 2.23

Price Performance

Historical Comparison
ARAY
KYNB

About ARAY Accuray Incorporated

Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention. The company has one operating segment which develops, manufactures and markets proprietary medical devices used in radiation therapy for the treatment of cancer patients.

About KYNB Kyntra Bio Inc. Common Stock

Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.

Share on Social Networks: